Article
FDA scrutinizes Novavax COVID-19 vaccine
WASHINGTON, D.C. — The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional protein-based option for the coronavirus — is also sowing uncertainty about updates to other vaccines. […]
